Industry

BOCA RATON, Fla. & SAN FRANCISCO–(BUSINESS WIRE)–Cross Country Healthcare, Inc. (NASDAQ: CCRN) (“Cross Country Healthcare” or the “Company”) a leading, technology-driven healthcare workforce solutions company, today announced that it has entered into a definitive agreement to be acquired by Knox Lane, a growth-oriented investment firm. Under the terms of the agreement, Knox Lane will acquire … [Read more…]

Facility strengthens balance sheet and provides additional financial flexibility to support execution of contracted project portfolio BURLINGTON, ONTARIO–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX: ANRG) (OTCQX: ANRGF), a global provider of integrated waste to-value solutions today announced that it has entered into a credit agreement (the “Credit Agreement”) with National Bank of … [Read more…]

Offering combines imaging, biomarkers, and physician-led insights to mitigate risks, support peak performance, and drive long-term value for executives and their organizations SAN MATEO, Calif. & NEW YORK–(BUSINESS WIRE)–Biograph, the world’s most advanced preventive health and diagnostics clinic, today announced the evolution of its Executive Physical, a world-class diagnostic experience that goes beyond traditional executive … [Read more…]

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at the Bank of America Securities Healthcare Conference 2026 on Thursday, May 14, 2026. The company will take part in a fireside chat beginning at 8:40 a.m. PT/11:40 a.m. ET. Investors and the general public are invited to listen to the … [Read more…]

Perfuse Therapeutics’ investigational lead program shows potential to become one of the first disease-modifying treatments for both Glaucoma and Diabetic Retinopathy (DR) High unmet medical need of patients with Glaucoma affecting up to 80 million people2 and Diabetic Retinopathy affecting around 146 million3 worldwide Acquisition complements Bayer’s pharmaceutical pipeline and strategically fits with Bayer’s footprint … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–$Innate #Biotech–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announces that the Company will hold a conference call on Wednesday, May 13, 2026 at 1:30 p.m. CEST / 7:30 a.m. EDT, to provide an update on business progress for the first quarter of 2026. Participants during … [Read more…]

BELO HORIZONTE, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that Moody’s reaffirmed Afya’s credit rating at AAA.br and maintained a stable outlook. The reaffirmation of Afya’s AAA.br rating and stable outlook reflects revenue growth, a track record … [Read more…]

First-quarter 2026 sales of $2.7 billion, up 10% on a reported basis, or up 6% constant currency1 (cc), versus first-quarter 2025 First-quarter 2026 diluted EPS of $0.39; core diluted EPS2 of $0.85 Dividend of 0.28 CHF per share approved at AGM Announced new $1.5 billion share repurchase authorization over 3 years Ad Hoc Announcement Pursuant … [Read more…]

ATLANTA–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield of Georgia today announced a new multi-year agreement with Northeast Georgia Health System (NGHS), a leading nonprofit health system serving more than one million people across Northeast Georgia. The agreement ensures Anthem commercial and Medicare Advantage members will continue to have uninterrupted, in-network access to NGHS’s comprehensive network … [Read more…]

Collaboration brings annually updated, evidence-based asthma strategy to a platform used by more than 40% of U.S. physicians FONTANA, Wis. & MIAMI–(BUSINESS WIRE)–#Asthma–The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA’s evidence-based asthma strategy reports, clinical recommendations, and educational resources available directly through OpenEvidence. Under the agreement, OpenEvidence becomes a key content … [Read more…]